News

The US Food and Drug Administration has approved a new treatment for neuromyelitis optica spectrum disorder among adults with the AQP4 antibody.
To investigate the etiology of acute flaccid myelitis, researchers examined cerebrospinal fluid samples from 29 children with AFM and 71 unmatched children with other neurologic diseases.